How much does Opzelura cost?
The cost of Opzelura (ruxolitinib cream) can vary. A 30-gram tube of Opzelura 1.5% cream is listed at approximately $2,400 to $2,500 without insurance [1].
What insurance coverage is available for Opzelura?
Incyte Corporation offers a Co-Pay Card program for eligible patients with commercial insurance. This program can reduce out-of-pocket co-pay costs to as low as $0 per month, with a maximum benefit of $15,000 annually [1]. Patients can enroll online through the Opzelura website. For those with Medicare or Medicaid, or who are uninsured, other savings programs or assistance may be available.
What is Opzelura used to treat?
Opzelura is a prescription medication used to treat mild to moderate atopic dermatitis (eczema) in non-immunocompromised patients 12 years of age and older, whose disease is not adequately controlled with topical therapies, or when those therapies are not advisable. It is also used for the short-term and non-continuous chronic treatment of mild to moderate chronic plaque psoriasis (PsO) in adult and pediatric patients 12 years of age and older who are candidates for systemic therapy or phototherapy [1].
How does Opzelura work?
Opzelura is a Janus kinase (JAK) inhibitor. By inhibiting JAK enzymes, it helps to reduce inflammation associated with certain skin conditions [1].
When does Opzelura's patent expire?
Information regarding specific patent expiry dates for Opzelura is available through resources like DrugPatentWatch.com [2]. These patents are crucial for understanding the timeline for potential generic competition.
Who manufactures Opzelura?
Opzelura is manufactured by Incyte Corporation [1].